Inactive Instrument

Immunosyn Corp Share Price

Equities

End-of-day quote Other OTC Other stock markets
- ^USD	-

IMMUNOSYN CORP COM STK USD0.0001 : Immunosyn Announces Proposed Agreements for Distribution of the Biopharmaceutical SF-1019 in Utah	16/08/16	PR
Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Corporation Files 10-Q	17/08/17	PR
Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Corporation Announces 2007 Results, Files 10KSB	01/08/01	PR
Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Releases Wound Healing Photographs From the First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019	26/08/26	PR
Immunosyn Corp Com Stk Usd0.0001 : Douglas A. McClain, Jr. Resumes CFO Duties at Immunosyn	02/08/02	PR

Managers	Title	Age	Since
Stephen D. Ferrone CEO	Chief Executive Officer	73	15/07/15
Douglas A. McClain DFI	Director of Finance/CFO	49	-

Members of the board	Title	Age	Since
Douglas A. McClain DFI	Director of Finance/CFO	49	-
Stephen D. Ferrone CEO	Chief Executive Officer	73	15/07/15

Sector

	1st Jan change	Capi.
CSL LIMITED	-2.06%	89.87B
SAMSUNG BIOLOGICS CO.,LTD.	-3.95%	37.57B
UCB	+63.05%	26.47B
BIOMARIN PHARMACEUTICAL INC.	-22.14%	14.25B
INCYTE CORPORATION	-7.96%	12.99B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9.33%	11.93B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-46.33%	10.84B
SWEDISH ORPHAN BIOVITRUM AB	+5.77%	9.11B
INNOVENT BIOLOGICS, INC.	-19.77%	7.32B